Target Price | $89.07 |
Price | $79.73 |
Potential |
11.71%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Hologic 2025 .
The average Hologic target price is $89.07.
This is
11.71%
register free of charge
$96.00
20.41%
register free of charge
$81.00
1.59%
register free of charge
|
|
A rating was issued by 21 analysts: 11 Analysts recommend Hologic to buy, 9 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Hologic stock has an average upside potential 2025 of
11.71%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 4.03 | 4.19 |
0.00% | 4.07% | |
EBITDA Margin | 31.74% | 33.26% |
1.17% | 4.79% |
17 Analysts have issued a sales forecast Hologic 2025 . The average Hologic sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Hologic EBITDA forecast 2025. The average Hologic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 3.32 | 3.58 |
81.42% | 7.83% | |
P/E | 22.29 | |
EV/Sales | 4.46 |
8 Analysts have issued a Hologic forecast for earnings per share. The average Hologic <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Hologic stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.